LONDON, December 9 /PRNewswire/ -- For the first time, US scientists have successfully identified gene expression and biological pathways involved in the onset and healing process of gingivitis, a condition affecting more than 50% of the UK adult population, and which if left untreated, can potentially lead to heart disease, diabetes and pre-term birth. This new research, which shows that development and reversal of gingivitis at the molecular level is much more complicated than its causes might indicate, is published in the Journal of Peridontology this week.
Dr Nigel Carter chief executive for the British Dental Health Foundation commenting on these findings said: Research has linked gum disease to a potential risk of heart disease, diabetes, strokes, premature births and low birth-weight babies, as well as tooth loss. Understanding how gingivitis (gum inflammation) develops and resolves on a molecular level, may provide critical insights into the prevention and treatment of gum disease. Gum disease affects most people at some point in their lives, so there is no excuse for ignoring good dental hygiene. People can help prevent gum disease developing by taking care of their teeth and gums by brushing twice a day with fluoride toothpaste, and cleaning between teeth with floss or interdental brushes. Using a power brush with a rotating oscillating head can help remove up to twice as much plaque. Always look for a brush recommended by the Foundation.
The research, 'Gingival Transcriptome Patterns during Induction and Resolution of Experimental Gingivitis in Humans', conducted by the University of North Carolina at Chapel Hill has found that more than 9,000 genes - approximately 30% of the genes found in the human body - are involved at the onset of gingivitis and the healing process. Gingivitis is characterized by gums that are red, swollen and tender and that bleed easily during brushing and flossing.
The study's findings demonstrate that clinical symptoms of gingivitis reflect complicated changes in cellular and molecular processes within the body, said Steven Offenbacher, D.D.S., Ph.D., the study's lead author and director of the UNC School of Dentistry-based Center for Oral and Systemic Diseases.
Understanding the thousands of individual genes and multiple systems involved in gingivitis will help explain exactly what is occurring in a person's body at the onset of the disease and how it relates to their overall health.
The build-up of plaque formed during the onset of gingivitis represents the overgrowth of bacteria as a biofilm on the teeth above and below the gum line. Biofilms can form in other parts of the body and are known to be involved with health conditions, such as urinary tract infections, ear infections and chronic sinusitis. Researchers believe learning about how the body interacts with bacteria overgrowth during gingivitis could provide insight into a variety of bio-film-associated diseases.
Data generated by the study will be crucial in developing new approaches to treating gingivitis, said Leslie Winston, D.D.S., Ph.D., co-author of the study and Director of Professional and Scientific Relations at PG Oral Care. We plan to conduct additional research to identify biomarkers of gum disease in at risk individuals and hope that this will lead to new and more advanced treatment options and preventative measures.
The study was supported by the National Institutes of Health in the USA and Procter Gamble.
Notes to editors:
About the Study
The objective of this study was to understand gingivitis on a molecular level by identifying changes in gene expression taking place in the mouth during gingivitis onset and the healing process. Fourteen healthy individuals with mild gingivitis participated in the study. After baseline tooth cleanings, gingivitis was induced in each study participant, followed by the participants adhering to an oral hygiene regimen of twice-daily brushing and regular flossing. Gum tissue was collected at baseline, four weeks after the induction of gingivitis and one week after resuming the oral hygiene regimen of brushing and flossing.
Gene expression data was analyzed using gene chip technology that enabled the investigators to detect changes in the expression of more than 30,000 genes. By applying advanced genomics bioinformatics tools, the investigators were able to identify the biological pathways and gene expression patterns associated with gingivitis.
As part of the study findings, researchers identified several biological pathways triggered by the onset and healing of gingivitis, including those associated with immune response, energy metabolism, neural processes, vasculature, chemotaxis, wound healing and steroid metabolism.
The study is published in the December 2009 edition (issued on 7th December) in the Journal of Periodontology, which is published by the American Academy of Periodontology (APP) and available at http://www.joponline.org/.
About the University of North Carolina at Chapel Hill School of Dentistry
The University of North Carolina at Chapel Hill School of Dentistry, which opened its doors to students in 1950, is among the leading public dental schools in the nation. The mission of the School of Dentistry is to promote the health of the people of North Carolina, the nation and the world through excellence in teaching, patient care, research and service.
Three billion times a day, PG brands touch the lives of people around the world. With more than 40 brands available in more than 80 countries, PG has one of the strongest portfolios of quality, leadership brands in health and well-being, including Always(R), Oral-B(R), Pepto-Bismol(R), Tampax(R), and Vicks(R). The PG community consists of more than 138,000 employees working in more than 80 countries worldwide. Please visit http://www.pg.com for the latest news and in-depth information about PG and its brands.
SOURCE: PSOURCE: G
CONTACT: For more information please contact: Shikira Austin, E:email@example.com , T: +44(0)20-7611-3578; Vanessa Allen, E:firstname.lastname@example.org , T: +44(0)20-7611-3599; Daisy Pack, E:email@example.com , T: +44(0)20-7611-3551.